Severity
Low
FDA Devices recall · Reported December 5, 2018
Discolored powder has confirmed the presence of a foreign substance
Fresenius Medical Care Renal Therapies Group, LLC recalled Fresenius Granuflo Dry Acid Concentrate- 3K 2.5 Ca 1 Mg 16.5 GAL Catalog Number: OFD3… - a low-severity action.
Fresenius Granuflo Dry Acid Concentrate- 3K 2.5 Ca 1 Mg 16.5 GAL Catalog Number: OFD3… was recalled by Fresenius Medical Care Renal Therapies Group, LLC in December 5, 2018. Reason: Discolored powder has confirmed the presence of a foreign substance. Check the official notice for the remedy. Verify recall #Z-0518-2019 with the FDA Devices before acting.
The recall
Fresenius Medical Care Renal Therapies Group, LLC issued this low-severity FDA Devices recall-Discolored powder has confirmed the presence of a foreign substance.
Sourced from official FDA Devices enforcement records. Verify recall #Z-0518-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0518-2019) was formally reported on December 5, 2018, with the manufacturer initiating the action on October 9, 2018. It is classified under Low severity (Class III), with a current status of Terminated. Fresenius Medical Care Renal Therapies Group, LLC is listed as the recalling firm, operating out of Waltham, MA. Federal records list the affected scope as 22320.
The documented reason for this recall is: Discolored powder has confirmed the presence of a foreign substance Distribution data in the federal record shows the product reached: Distribution US nationwide and Mexico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
22320
Related Recalls
6
3 from same agency
Fresenius Granuflo Dry Acid Concentrate- 3K 2.5 Ca 1 Mg 16.5 GAL Catalog Number: OFD3251-3B for hemodialysis
Discolored powder has confirmed the presence of a foreign substance
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | Z-0518-2019 |
| Date reported | December 5, 2018 |
| Date initiated | October 9, 2018 |
| Recalling firm | Fresenius Medical Care Renal Therapies Group, LLC |
| Firm location | Waltham, MA |
| Affected scope | 22320 |
| Distribution | Distribution US nationwide and Mexico |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported December 5, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.